Feasibility of melatonin for prevention of delirium in critically ill patients: a protocol for a multicentre, randomised, placebo-controlled study

Lisa Burry, Damon Scales, David Williamson, Jennifer Foster, Sangeeta Mehta, Melanie Guenette, Eddy Fan, Michael Detsky, Azar Azad, Francis Bernard, Louise Rose, Lisa Burry, Damon Scales, David Williamson, Jennifer Foster, Sangeeta Mehta, Melanie Guenette, Eddy Fan, Michael Detsky, Azar Azad, Francis Bernard, Louise Rose

Abstract

Introduction: Delirium is highly prevalent in the intensive care unit (ICU) and is associated with adverse clinical outcomes. At this time, there is no drug that effectively prevents delirium in critically ill patients. Alterations in melatonin secretion and metabolism may contribute to the development of delirium. Administration of exogenous melatonin has been shown to prevent delirium in non-critically ill surgical and medical patients. This trial will demonstrate the feasibility of a planned multicentre, randomised controlled trial to test the hypothesis that melatonin can prevent delirium in critically ill patients compared with placebo.

Methods and analysis: This feasibility trial is a randomised, 3-arm, placebo-controlled study of melatonin (2 vs 0.5 mg vs placebo, administered for a maximum of 14 days) for the prevention of delirium in critically ill patients. A total of 69 patients aged 18 years and older with an expected ICU length of stay >48 hours will be recruited from 3 Canadian ICUs. The primary outcome is protocol adherence (ie, overall proportion of study drug doses administered in the prescribed administration window). Secondary outcomes include pharmacokinetic parameters, incidence, time to onset, duration of delirium, number of delirium-free days, adverse events, self-reported sleep quality, rest-activity cycles measured by wrist actigraphy, duration of mechanical ventilation, ICU length of stay and mortality. Data will be analysed using an intention-to-treat approach.

Ethics and dissemination: The study has been approved by Health Canada and the research ethics board of each study site. Trial results will be presented at international conferences and published in a peer-reviewed journal.

Trial registration number: NCT02615340: Pre-results.

Keywords: INTENSIVE & CRITICAL CARE; melatonin.

Conflict of interest statement

Competing interests: None declared.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

References

    1. Association AP. Diagnostic and statistical manual of mental disorders (fifth ed.). 5th edn Arlington, VA, USA: American Psychiatric Association, 2013.
    1. Bruera E, Bush SH, Willey J et al. . Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers. Cancer 2009;115:2004–12. 10.1002/cncr.24215
    1. Breitbart W, Gibson C, Tremblay A. The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics 2002;43:183–94. 10.1176/appi.psy.43.3.183
    1. Barr J, Fraser GL, Puntillo K et al. . Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013;41:263–306. 10.1097/CCM.0b013e3182783b72
    1. van den Boogaard M, Schoonhoven L, Evers AW et al. . Delirium in critically ill patients: impact on long-term health-related quality of life and cognitive functioning. Crit Care Med 2012;40:112–8. 10.1097/CCM.0b013e31822e9fc9
    1. Pisani MA, Kong SY, Kasl SV et al. . Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med 2009;180:1092–7. 10.1164/rccm.200904-0537OC
    1. Lin SM, Liu CY, Wang CH et al. . The impact of delirium on the survival of mechanically ventilated patients. Crit Care Med 2004;32:2254–9. 10.1097/
    1. Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet 2014;383:911–22. 10.1016/S0140-6736(13)60688-1
    1. Girard TD, Jackson JC, Pandharipande PP et al. . Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med 2010;38:1513–20. 10.1097/CCM.0b013e3181e47be1
    1. Ely EW, Shintani A, Truman B et al. . Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004;291:1753–62. 10.1001/jama.291.14.1753
    1. Flacker JM, Lipsitz LA. Neural mechanisms of delirium: current hypotheses and evolving concepts. J Gerontol A Biol Sci Med Sci 1999;54:B239–46. 10.1093/gerona/54.6.B239
    1. de Rooij SE, van Munster BC, Korevaar JC et al. . Cytokines and acute phase response in delirium. J Psychosom Res 2007;62:521–5. 10.1016/j.jpsychores.2006.11.013
    1. Weinhouse GL, Schwab RJ, Watson PL et al. . Bench-to-bedside review: delirium in ICU patients—importance of sleep deprivation. Crit Care 2009;13:234 10.1186/cc8131
    1. Brzezinski A. Melatonin in humans. N Engl J Med 1997;336:186–95. 10.1056/NEJM199701163360306
    1. Yoshitaka S, Egi M, Morimatsu H et al. . Perioperative plasma melatonin concentration in postoperative critically ill patients: its association with delirium. J Crit Care 2013;28:236–42. 10.1016/j.jcrc.2012.11.004
    1. Shigeta H, Yasui A, Nimura Y et al. . Postoperative delirium and melatonin levels in elderly patients. Am J Surg 2001;182:449–54. 10.1016/S0002-9610(01)00761-9
    1. Perras B, Kurowski V, Dodt C. Nocturnal melatonin concentration is correlated with illness severity in patients with septic disease. Intensive Care Med 2006;32:624–5. 10.1007/s00134-006-0069-x
    1. Olofsson K, Alling C, Lundberg D et al. . Abolished circadian rhythm of melatonin secretion in sedated and artificially ventilated intensive care patients. Acta Anaesthesiol Scand 2004;48:679–84. 10.1111/j.0001-5172.2004.00401.x
    1. Mundigler G, Delle-Karth G, Koreny M et al. . Impaired circadian rhythm of melatonin secretion in sedated critically ill patients with severe sepsis. Crit Care Med 2002;30:536–40. 10.1097/00003246-200203000-00007
    1. Miyazaki T, Kuwano H, Kato H et al. . Correlation between serum melatonin circadian rhythm and intensive care unit psychosis after thoracic esophagectomy. Surgery 2003;133:662–8. 10.1067/msy.2003.149
    1. Haimov I. Melatonin rhythm abnormalities and sleep disorders in the elderly. CNS Spectr 2001;6:502–6. 10.1017/S109285290000804X
    1. Robinson TN, Raeburn CD, Angles EM et al. . Low tryptophan levels are associated with postoperative delirium in the elderly. Am J Surg 2008;196:670–4. 10.1016/j.amjsurg.2008.07.007
    1. Pandharipande PP, Morandi A, Adams JR et al. . Plasma tryptophan and tyrosine levels are independent risk factors for delirium in critically ill patients. Intensive Care Med 2009;35:1886–92. 10.1007/s00134-009-1573-6
    1. Balan S, Leibovitz A, Zila SO et al. . The relation between the clinical subtypes of delirium and the urinary level of 6-SMT. J Neuropsychiatry Clin Neurosci 2003;15:363–6. 10.1176/jnp.15.3.363
    1. Mo Y, Scheer CE, Abdallah GT. Emerging role of melatonin and melatonin receptor agonists in sleep and delirium in intensive care unit patients. J Intensive Care Med 2016;31:451–5. 10.1177/0885066615592348
    1. Wyatt JK, Dijk DJ, Ritz-de Cecco A et al. . Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent. Sleep 2006;29:609–18.
    1. Zaal IJ, Devlin JW, Peelen LM et al. . A systematic review of risk factors for delirium in the ICU. Crit Care Med 2015;43:40–7. 10.1097/CCM.0000000000000625
    1. Wolters AE, Zaal IJ, Veldhuijzen DS et al. . Anticholinergic medication use and transition to delirium in critically ill patients: a prospective cohort study. Crit Care Med 2015;43:1846–52. 10.1097/CCM.0000000000001094
    1. Sultan SS. Assessment of role of perioperative melatonin in prevention and treatment of postoperative delirium after hip arthroplasty under spinal anesthesia in the elderly. Saudi J Anaesth 2010;4:169–73. 10.4103/1658-354X.71132
    1. de Jonghe A, van Munster BC, Goslings JC et al. . Effect of melatonin on incidence of delirium among patients with hip fracture: a multicentre, double-blind randomized controlled trial. Can Med Assoc J 2014;186:E547–E56. 10.1503/cmaj.140495
    1. Al-Aama T, Brymer C, Gutmanis I et al. . Melatonin decreases delirium in elderly patients: a randomized, placebo-controlled trial. Int J Geriatr Psychiatry 2011;26:687–94. 10.1002/gps.2582
    1. Hatta K, Kishi Y, Wada K et al. . Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. JAMA Psychiatry 2014;71:397–403. 10.1001/jamapsychiatry.2013.3320
    1. Chen S, Shi L, Liang F et al. . Exogenous melatonin for delirium prevention: a meta-analysis of randomized controlled trials. Mol Neurobiol 2016;53:4046–53. 10.1007/s12035-015-9350-8
    1. Bergeron N, Dubois MJ, Dumont M et al. . Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med 2001;27:859–64. 10.1007/s001340100909
    1. Riker RR, Picard JT, Fraser GL. Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med 1999;27:1325–9. 10.1097/00003246-199907000-00022
    1. Richards KC, O'Sullivan PS, Phillips RL. Measurement of sleep in critically ill patients. J Nurs Meas 2000;8:131–44.
    1. Richards K. Techniques for measurement of sleep in critical care. Focus Crit Care 1987;14:34–40.
    1. Singer C, Tractenberg RE, Kaye J et al. . A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep 2003;26:893–901.
    1. Olde Rikkert MG, Rigaud AS. Melatonin in elderly patients with insomnia. A systematic review. Z Gerontol Geriatr 2001;34:491–7. 10.1007/s003910170025
    1. Buscemi N, Vandermeer B, Hooton N et al. . Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ 2006;332:385–93. 10.1136/bmj.38731.532766.F6
    1. Bjorvatn B, Pallesen S. A practical approach to circadian rhythm sleep disorders. Sleep Med Rev 2009;13:47–60. 10.1016/j.smrv.2008.04.009
    1. Bourne RS, Mills GH, Minelli C. Melatonin therapy to improve nocturnal sleep in critically ill patients: Encouraging results from a small randomised controlled trial. Crit Care 2008;12:R52 10.1186/cc6871
    1. Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev 2002;(2):CD001520 10.1002/14651858.CD001520
    1. McDonald ETA, Zytaruk N, Julien L et al. . Critical Care Canada Trials Group. PROSPECT-TIMES: a time-in-motion evaluation study. Am J Respir Crit Care Med 2007;175:A594a.
    1. Mistraletti G, Sabbatini G, Taverna M et al. . Pharmacokinetics of orally administered melatonin in critically ill patients. J Pineal Res 2010;48:142–7. 10.1111/j.1600-079X.2009.00737.x
    1. Bourne RS, Mills GH. Melatonin: possible implications for the postoperative and critically ill patient. Intensive Care Med 2006;32:371–9. 10.1007/s00134-005-0061-x
    1. Bellapart J, Roberts JA, Appadurai V et al. . Pharmacokinetics of a novel dosing regimen of oral melatonin in critically ill patients. Clin Chem Lab Med 2016;54:467–72. 10.1515/cclm-2015-0323
    1. Gusmao-Flores D, Salluh JI, Chalhub RA et al. . The confusion assessment method for the intensive care unit (CAM-ICU) and intensive care delirium screening checklist (ICDSC) for the diagnosis of delirium: a systematic review and meta-analysis of clinical studies. Crit Care 2012;16:R115 10.1186/cc11407
    1. Ouimet S, Riker R, Bergeron N et al. . Subsyndromal delirium in the ICU: evidence for a disease spectrum. Intensive Care Med 2007;33:1007–13. 10.1007/s00134-007-0618-y
    1. Kamdar BB, Shah PA, King LM et al. . Patient-nurse interrater reliability and agreement of the Richards-Campbell sleep questionnaire. Am J Crit Care 2012;21:261–9. 10.4037/ajcc2012111
    1. Practice parameters for the indications for polysomnography and related procedures. Polysomnography Task Force, American Sleep Disorders Association Standards of Practice Committee. Sleep 1997;20:406–22.
    1. Kushida CA, Littner MR, Morgenthaler T et al. . Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 2005;28:499–521.
    1. Martin JL, Hakim AD. Wrist actigraphy. Chest 2011;139:1514–27. 10.1378/chest.10-1872
    1. Cook D, Lauzier F, Rocha MG et al. . Serious adverse events in academic critical care research. CMAJ 2008;178:1181–4. 10.1503/cmaj.071366
    1. Group ItSCTW. Initiative to streamline clinical trials. Secondary Initiative to streamline clinical trials 2014.
    1. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974;2:81–4.
    1. Ferreira FL, Bota DP, Bross A et al. . Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001;286:1754–8. 10.1001/jama.286.14.1754
    1. Kwan Y, Fernandes OA, Nagge JJ et al. . Pharmacist medication assessments in a surgical preadmission clinic. Arch Intern Med 2007;167:1034–40. 10.1001/archinte.167.10.1034
    1. Canadian Institutes of Health Research NSaERCoC, and Social Sciences and Humanities Research Council of Canada. Tri-council policy statement: ethical conduct for research involving humans. Ottawa, ON: Government of Canada, 2014.
    1. Schulz KF, Altman DG, Moher D et al. . CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 2010;63:834–40. 10.1016/j.jclinepi.2010.02.005

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する